| The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years MM Elfishawi, N Zleik, Z Kvrgic, CJ Michet, CS Crowson, EL Matteson, ... The Journal of rheumatology 45 (4), 574-579, 2018 | 157 | 2018 |
| Hospitalization increases the risk of acute arthritic flares in gout: a population-based study over 2 decades N Zleik, MM Elfishawi, Z Kvrgic, CJ Michet, CS Crowson, EL Matteson, ... The Journal of rheumatology 45 (8), 1188-1191, 2018 | 24 | 2018 |
| Rheumatoid arthritis: a single-center Egyptian experience BR Sakr, MM Elfishawi, MH ElArousy, AK Hatw, AN AbdulKarim, ... Immunological investigations 47 (3), 293-302, 2018 | 19 | 2018 |
| Dapagliflozin-induced acute pancreatitis: a case report and review of literature SM Sujanani, MM Elfishawi, P Zarghamravanbaksh, FJC Castillo, ... Case Reports in Endocrinology 2020, 2020 | 17 | 2020 |
| HLA Class I in Egyptian patients with Behçet’s disease: new association with susceptibility, protection, presentation and severity of manifestations MM Elfishawi, F Elgengehy, G Mossallam, S Elfishawi, M Alfishawy, ... Immunological investigations 48 (2), 121-129, 2019 | 16 | 2019 |
| Changes in the presentation of incident gout and the risk of subsequent flares: a population-based study over 20 years MM Elfishawi, N Zleik, Z Kvrgic, CJ Michet, CS Crowson, EL Matteson, ... The Journal of rheumatology 47 (4), 613-618, 2020 | 14 | 2020 |
| Fahr’s disease: a differential to be considered for various neuropsychiatric presentations S Pourshahid, MN Salloum, M Elfishawi, M Barakat, M Basith, ... Cureus 10 (3), 2018 | 12 | 2018 |
| Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction HMA Ahmed, S Abohamad, M Elfishawi, MT Hegazy, K Vijaykumar Patient preference and adherence, 2475-2479, 2018 | 11 | 2018 |
| Behcet disease, new insights in disease associations and manifestations: a next-generation sequencing study M Elfishawi, G Mossallam, DG Augusto, G Montero-Martin, H de Bruin, ... Clinical & Experimental Immunology 204 (1), 144-151, 2021 | 8 | 2021 |
| Lower frequency of comorbidities prior to onset of giant cell arteritis: a population-based study M Elfishawi, J Rakholiya, TM Gunderson, SJ Achenbach, CS Crowson, ... The Journal of rheumatology 50 (4), 526-531, 2023 | 6 | 2023 |
| Monckeberg medial calcific sclerosis of the temporal artery masquerading as giant cell arteritis: case reports and literature review FJC Castillo, S Sujanani, VK Chetram, M Elfishawi, A Abrudescu Cureus 12 (7), 2020 | 6 | 2020 |
| The epidemiology of pathologically confirmed clinically isolated aortitis: a North American population-based study M Kaymakci, M Elfishawi, HE Langenfeld, CS Crowson, CM Weyand, ... Clinical and experimental rheumatology 41 (4), 956, 2023 | 5 | 2023 |
| Persistent aortic inflammation in patients with giant cell arteritis MS Kaymakci, NA Boire, MC Bois, MM Elfishawi, HE Langenfeld, ... Autoimmunity Reviews, 103411, 2023 | 4 | 2023 |
| Urethral involvement in granulomatosis with polyangiitis: a case-based review HMA Ahmed, MM Elfishawi, A Hagiga, IMA Ahmed, YL Chen Rheumatology International 39 (7), 1279-1284, 2019 | 4 | 2019 |
| Clinical Images: IgG4‐related disease: a giant cell arteritis mimic M Kaymakci, M Elfishawi, MJ Koster, PD Hurst, KJ Warrington Arthritis & Rheumatology 75 (7), 1262-1262, 2023 | 3 | 2023 |
| Diabetic ketoacidosis with two life threatening infections: mucormycosis, and bilateral emphysematous pyelonepritis, preciptating erythema nodosum leprosum as the initial … A Daoud, A Elbendary, M Elfishawi, M Rabea, M Alfishawy J Diabetes Metab 5 (433), 2, 2014 | 3 | 2014 |
| Intestinal pseudo-obstruction as the initial clinical presentation in systemic lupus erythematosus: a rare and severe disorder A Nyabera, M Elfishawi, F Cuevas, F Riaz, A Abrudescu Case Reports in Gastrointestinal Medicine 2020, 2020 | 2 | 2020 |
| AB0781 LARGE VESSEL INVOLVEMENT IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS M Kaymakci, M Elfishawi, H Langenfeld, A Hanson, CS Crowson, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1600-1601, 2023 | 1 | 2023 |
| Smoldering giant cell arteritis in a coronary artery M Kaymakci, M Elfishawi, MP Alexander, MJ Koster, KJ Warrington Rheumatology 61 (12), e384-e385, 2022 | 1 | 2022 |
| Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis; A Population-based Study J Rakholiya, M Elfishawi, T Gunderson, C Crowson, E Matteson, ... ARTHRITIS & RHEUMATOLOGY 73, 2937-2940, 2021 | 1 | 2021 |
